Keywords: Liver, Treatment Response
Motivation: Three-dimensional magnetic resonance elastography (3D-MRE) can detect necroinflammation and fibrosis in chronic hepatitis B (CHB) patients. However, few studies have examined the ability of 3D-MRE to monitor liver changes in CHB patients, both with and without antiviral treatment.
Goal(s): To develop a non-invasive follow-up method using 3D-MRE for both treated and untreated CHB patients.
Approach: Cohen’s Kappa test compared the agreement between disease progression diagnosed by pathology or clinical criteria and that diagnosed by MRE. Spearman correlation analysis was performed between changes in 3D-MRE and liver histology or clinical indicators during follow-up.
Results: 3D-MRE effectively monitors disease progression in CHB patients during follow-up.
Impact: 3D-MRE offers a non-invasive biomarker for longitudinal monitoring in CHB patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords